Skip to main content
. 2022 Feb 18;1258:132652. doi: 10.1016/j.molstruc.2022.132652

Fig. 5.

Fig 5

RMSD for (a) Phylloquinone oxide-protein complex; (b) Riboflavin-protein complex; and (c) folacin-protein complex based on ‘C-alpha’ atoms. RMSD for (a)* Phylloquinone oxide-protein complex; (b)* Riboflavin-protein complex; and (c)* Folacin-protein complex based on respective ligand's atoms.